The Landscape of Currently Enrolling Maintenance Trials in Multiple Myeloma

被引：3
|
作者：
Syed Maaz Tariq
Al-Ola Abdallah
Aaron Goodman
Douglas Sborov
Ghulam Rehman Mohyuddin
Alec Britt
机构：
[1] Jinnah Sindh Medical University,Division of Hematological Malignancies and Cellular Therapeutics
[2] University of Kansas Medical Center,Division of Hematology and Oncology
[3] University of California San Diego,Division of Hematology and Hematological Malignancies
[4] University of Utah,undefined
来源：
Clinical Hematology International | 2023年 / 5卷 / 2-3期
关键词：
Myeloma; Landscape; Lenalidomide; Maintenance;
D O I：
10.1007/s44228-023-00044-8
中图分类号：
学科分类号：
摘要：
Maintenance therapies in multiple myeloma improve survival after induction treatment. This study characterizes the strategies for maintenance therapy being employed in currently enrolling clinical trials for patients with multiple myeloma and highlights how high-risk myeloma patients may be assigned to maintenance strategies incongruent with current US guidelines.
引用
收藏
页码：170 / 176
页数：6
相关论文
共 50 条
  • [1] The Landscape of Maintenance Therapy Trials Following Autologous Transplant for Multiple Myeloma
    Britt, Alec
    Tariq, Syed Maaz
    Sborov, Douglas W.
    Abdallah, Al-Ola
    Goodman, Aaron M.
    Mohyuddin, Ghulam Rehman
    BLOOD, 2022, 140 : 12510 - 12512
  • [2] Inclusion criteria of currently enrolling T-cell engaging trials in multiple myeloma: Should we be focusing on lines of prior therapy?
    Mohyuddin, Ghulam Rehman
    Kapur, Rohan
    Costa, Luciano
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 202 (01) : E1 - E2
  • [3] Monoclonal antibodies currently in Phase II and III trials for multiple myeloma
    Donato, Francesca
    Gay, Francesca
    Bringhen, Sara
    Troia, Rossella
    Palumbo, Antonio
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2014, 14 (08) : 1127 - 1144
  • [4] Posttransplant maintenance therapy in multiple myeloma: the changing landscape
    S Sengsayadeth
    F Malard
    B N Savani
    L Garderet
    M Mohty
    Blood Cancer Journal, 2017, 7 : e545 - e545
  • [5] Posttransplant maintenance therapy in multiple myeloma: the changing landscape
    Sengsayadeth, S.
    Malard, F.
    Savani, B. N.
    Garderet, L.
    Mohty, M.
    BLOOD CANCER JOURNAL, 2017, 7 : e545 - e545
  • [6] Exploring the multiple myeloma maintenance treatment landscape in Austria
    Willenbacher, E.
    Agis, H.
    Krauth, M.
    Sormann, S.
    Weger, R.
    Bauer, F.
    Hartmann, B.
    Willenbacher, W.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 113 - 113
  • [7] Quality of control groups in randomised trials of multiple myeloma enrolling in the USA: a systematic review
    Mohyuddin, Ghulam Rehman
    Koehn, Kelly
    Sborov, Douglas
    McClune, Brian
    Abdallah, Al-Ola
    Goodman, Aaron M.
    Prasad, Vinay
    LANCET HAEMATOLOGY, 2021, 8 (04): : E299 - E304
  • [8] Enrolling Patients Into Multiple Trials: It Is Time for Glasnost
    Cinnella, Gilda
    CRITICAL CARE MEDICINE, 2015, 43 (02) : 485 - 486
  • [9] The unique challenges of enrolling patients into multiple clinical trials
    Randolph, Adrienne G.
    CRITICAL CARE MEDICINE, 2009, 37 (01) : S107 - S111
  • [10] The landscape of clinical trials for heavily pretreated multiple myeloma: opportunity for more randomization?
    Kapur, Rohan
    Mccarron, John
    Rajeeve, Sridevi
    Mohyuddin, Ghulam Rehman
    LEUKEMIA & LYMPHOMA, 2025, 66 (02) : 355 - 357
12345